002620.KO Jeil Pharm

Healthcare Pharmaceuticals Korea Stock Exchange
6,830 KRW
Close of Nov 5, 2026
6,050 9,850
Market cap
KRW 105B
P/E
12.2x
P/B
0.33x
ROE
-1.6%
Dividend yield
0.17%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 002620.KO undervalued?

Graham number
Price6,830
Graham value16,175
Discount57.8%

002620.KO trades 57.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jeil Pharm fundamental analysis

No fundamental analysis for Jeil Pharm yet.

Jeil Pharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jeil Pharm

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocr…

Full company profile